Media Partners

Delveinsight logo CAR-T


DelveInsight is a consulting and market research firm with expertise around healthcare and pharmaceutical market. With a global outreach, DelveInsight serves pharma and biotech firms by publishing actionable and high-quality market analysis across the drug value chain.
DelveInsight proffers services ranging from market forecast analysis to drug-launch and pipeline insights and to identify and forecast epidemiology patterns across vast therapeutic areas. The company supports its clients from pre-clinal phase till the commercialization phase by customised business service offerings to support their strategies. Additionally, through its consulting solutions, DelveInsight has established itself as one of the most sought-after service providers in the healthcare business consulting domain.

Endpoints logo

Endpoints News

Endpoints News is an independent news organization, reporting and analyzing the top global biopharma R&D news of the day — for professionals discovering, developing, and marketing biopharmaceutical drugs.

genetherapynetbanner234x60 - jpg

Gene Therapy Net

Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines.

TMM logo_Orange

The Medicine Maker

The development and manufacture of small molecules, biologics, and advanced therapies draws on the talent, passion and experience of a wide range of professionals. The Medicine Maker is a global publication that brings these people into the limelight, showcasing the pharma industry’s success stories and examining its biggest points of contention. Engaging content covers the entire spectrum of drug development, keeping all medicine makers up to date with the most pressing topics, trends and technologies driving the drug development and manufacturing industry forward.


Stat News

STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis.